Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma

CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 1995–1999. Central Brain Tumor Registry of the United States: Chicago, IL, 2002.

Kleihues, 2000, Glioblastoma, 29

Taveras, 1962, Should we treat glioblastoma multiforme? A study of survival in 425 cases, Am J Roentg, 87, 473

Mandonnet, 2003, Continuous growth of mean tumor diameter in a subset of grade II gliomas, Ann Neurol, 53, 524, 10.1002/ana.10528

Swanson, 2003, Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion, J Neurol Sci, 216, 1, 10.1016/j.jns.2003.06.001

Brat, 2002, Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation, Adv Anat Pathol, 9, 24, 10.1097/00125480-200201000-00004

Daumas-Duport, 1988, Grading of astrocytomas. A simple and reproducible method, Cancer, 62, 2152, 10.1002/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T

Plate, 1992, Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo, Nature, 359, 845, 10.1038/359845a0

Plate, 1999, Mechanisms of angiogenesis in the brain, J Neuropathol Exp Neurol, 58, 313, 10.1097/00005072-199904000-00001

Takano, 1996, Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients, Cancer Res, 56, 2185

Shweiki, 1999, Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis, Nature, 359, 843, 10.1038/359843a0

Semenza, 2001, Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology, Trends Mol Med, 7, 345, 10.1016/S1471-4914(01)02090-1

Kung, 2000, Suppression of tumor growth through disruption of hypoxia-inducible transcription, Nat Med, 6, 1335, 10.1038/82146

Plate, 1994, Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms, Int J Cancer, 59, 520, 10.1002/ijc.2910590415

Brat, 2001, Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research, Am J Pathol, 158, 789, 10.1016/S0002-9440(10)64025-4

Straume, 2002, Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers, Cancer Res, 62, 6808

Bellail A, Hunter SB, Brat DJ, et al. Microregional extracellular molecular heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol, (in press).

Rieger, 1998, APO2 ligand: a novel lethal weapon against malignant glioma?, FEBS Lett, 427, 124, 10.1016/S0014-5793(98)00409-8

Hao, 2001, Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells, Cancer Res, 61, 1162

Tachibana, 1995, Expression of Fas/APO-1 during the progression of astrocytomas, Cancer Res, 55, 5528

Gratas, 1997, Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors, Brain Pathol, 7, 863, 10.1111/j.1750-3639.1997.tb00889.x

Tachibana, 1996, Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme, Acta Neuropathol (Berl), 92, 431, 10.1007/s004010050542

Takekawa, 1999, Expression of apoptosis and its related protein in astrocytic tumors, Brain Tumor Pathol, 16, 11, 10.1007/BF02478896

Saas, 1997, Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?, J Clin Invest, 99, 1173, 10.1172/JCI119273

Migheli, 1994, A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks, J Neuropathol Exp Neurol, 53, 606, 10.1097/00005072-199411000-00008

Schiffer, 1995, Apoptosis and cell proliferation in human neuroepithelial tumors, Neurosci Lett, 195, 81, 10.1016/0304-3940(95)11784-T

Nelson, 1983, Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas, Cancer, 52, 550, 10.1002/1097-0142(19830801)52:3<550::AID-CNCR2820520327>3.0.CO;2-C

Lacroix, 2001, A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival, J Neurosurg, 95, 190, 10.3171/jns.2001.95.2.0190

Burger, 1987, Patient age, histologic features, and length of survival in patients with glioblastoma multiforme, Cancer, 59, 1617, 10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X

Curran, 1993, Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials, J Natl Cancer Inst, 85, 704, 10.1093/jnci/85.9.704

Raza, 2002, Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis, Neurosurgery, 51, 2, 10.1097/00006123-200207000-00002

Dinda, 1993, A transmission and scanning electron microscopic study of tumoral and peritumoral microblood vessels in human gliomas, J Neurooncol, 16, 149, 10.1007/BF01324702

Sawaya, 1995, Plasminogen activator inhibitor-1 in brain tumors: relation to malignancy and necrosis, Neurosurgery, 36, 375, 10.1227/00006123-199502000-00018

Hamada, 1996, Expression of tissue factor correlates with grade of malignancy in human glioma, Cancer, 77, 1877, 10.1002/(SICI)1097-0142(19960501)77:9<1877::AID-CNCR18>3.0.CO;2-X

Sawaya, 1991, Biological significance of tissue plasminogen activator content in brain tumors, J Neurosurg, 74, 480, 10.3171/jns.1991.74.3.0480

Brat, 2004, Pseudopalisading cells in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by a rapidly migrating population, Cancer Res, 64, 910, 10.1158/0008-5472.CAN-03-2073

Zagzag, 2000, Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression, Cancer, 88, 2606, 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W

Krishnamachary, 2003, Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1, Cancer Res, 63, 1138

Pennacchietti, 2003, Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene, Cancer Cell, 3, 347, 10.1016/S1535-6108(03)00085-0

Ben-Yosef, 2002, Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation, Circ Res, 90, 784, 10.1161/01.RES.0000015588.70132.DC

Graham, 1999, Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression, Int J Cancer, 80, 617, 10.1002/(SICI)1097-0215(19990209)80:4<617::AID-IJC22>3.0.CO;2-C

Yamamoto, 1996, Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivoin vitro, Cancer Res, 56, 384

Mori, 2000, Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor, J Neurooncol, 46, 115, 10.1023/A:1006339717748

Holash, 1999, Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF, Science, 284, 1994, 10.1126/science.284.5422.1994

Zagzag, 2000, Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma and angiogenesis, Lab Invest, 80, 837, 10.1038/labinvest.3780088

Zagzag, 1999, In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis, Exp Neurol, 159, 391, 10.1006/exnr.1999.7162

Stratmann, 1998, Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis, Am J Pathol, 153, 1459, 10.1016/S0002-9440(10)65733-1

Vajkoczy, 2002, Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2, Clin Invest, 109, 777, 10.1172/JCI0214105

Zhang, 2003, Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer, Cancer Res, 63, 3403

Yu, 2001, Angiopoietin-2 is implicated in the regulation of tumor angiogenesis, Am J Pathol, 158, 563, 10.1016/S0002-9440(10)63998-3

Maisonpierre, 1997, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis, Science, 277, 55, 10.1126/science.277.5322.55

Rickles, 2001, Molecular basis for the relationship between thrombosis and cancer, Thromb Res, 102, V215, 10.1016/S0049-3848(01)00285-7

Walsh, 2001, Thromboembolism in brain tumors, Curr Opin Pulm Med, 7, 326, 10.1097/00063198-200109000-00013

Rodas, 1998, Correlation of intraluminal thrombosis in brain tumor vessels with postoperative thrombotic complications: a preliminary report, J Neurosurg, 89, 200, 10.3171/jns.1998.89.2.0200

Kniesel, 2000, Tight junctions of the blood–brain barrier, Cell Mol Neurobiol, 20, 57, 10.1023/A:1006995910836

Long, 1970, Capillary ultrastructure and the blood–brain barrier in human malignant brain tumors, J Neurosurg, 32, 127, 10.3171/jns.1970.32.2.0127

Zhu, 2000, Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging, J Magn Reson Imaging, 11, 575, 10.1002/1522-2586(200006)11:6<575::AID-JMRI2>3.0.CO;2-1

Sugahara, 1998, Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas, AJR Am J Roentgenol, 171, 1479, 10.2214/ajr.171.6.9843274

Rascher, 2002, Extracellular matrix and the blood–brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin, Acta Neuropathol (Berl), 104, 85, 10.1007/s00401-002-0524-x

Senger, 1983, Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid, Science, 219, 983, 10.1126/science.6823562

Fischer, 1999, Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO, Am J Physiol, 276, C812, 10.1152/ajpcell.1999.276.4.C812

Versteeg, 2003, Tissue factor signal transduction in angiogenesis, Carcinogenesis, 24, 1009, 10.1093/carcin/bgg039

Contrino, 1996, In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease, Nat Med, 2, 209, 10.1038/nm0296-209

Vrana, 1996, Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family, Cancer Res, 56, 5063

Seto, 2000, Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis, Cancer, 88, 295, 10.1002/(SICI)1097-0142(20000115)88:2<295::AID-CNCR8>3.0.CO;2-U

Guan, 2002, Tissue factor expression and angiogenesis in human glioma, Clin Biochem, 35, 321, 10.1016/S0009-9120(02)00312-0

Yan, 1999, Hypoxia/hypoxemia-induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis, Arterioscler Thromb Vasc Biol, 19, 2029, 10.1161/01.ATV.19.9.2029

Lawson, 1997, Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation, J Clin Invest, 99, 1729, 10.1172/JCI119337

Yan, 1999, Hypoxia-associated induction of early growth response-1 gene expression, Biol Chem, 274, 15030, 10.1074/jbc.274.21.15030

Coughlin, 2000, Thrombin signalling and protease-activated receptors, Nature, 407, 258, 10.1038/35025229

Macfarlane SR, Seatter MJ, Kanke T, et al. Pharmacol Rev 2001;53:245–282.

Even-Ram, 1998, Thrombin receptor overexpression in malignant and physiological invasion processes, Nat Med, 4, 909, 10.1038/nm0898-909

Darmoul, 2003, Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells, Am J Pathol, 162, 1503, 10.1016/S0002-9440(10)64283-6

Martin, 2001, The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways, Oncogene, 20, 1953, 10.1038/sj.onc.1204281

Marinissen, 2003, The thrombin receptor PAR-1 signals through Gq and G13-initiated MAPK cascades regulating c-jun expression to induce cell transformation, J Biol Chem, 278, 46814, 10.1074/jbc.M305709200

Yin, 2003, Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness, Arterioscler Thromb Vasc Biol, 23, 940, 10.1161/01.ATV.0000066878.27340.22

Even-Ram, 2001, Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin, J Biol Chem, 276, 10952, 10.1074/jbc.M007027200

Junge, 2003, The contribution of protease activated receptor-1 to neuronal damage caused by transient focal ischemia, Proc Natl Acad Sci USA, 100, 13019, 10.1073/pnas.2235594100

Junge CE, Lee CJ, Hubbard KB, et al. Protease activated receptor-1 (PAR1) in human brain: localization and functional expression in astrocytes. Exper Neurol, (in press).